Participated · Series A · Sep 2025

Founded in 2021 by Silvia Wang and Daniele Francescon, Serenis operates an online, medically-licensed platform that matches patients with 2,500 experienced psychologists, psychiatrists and nutritionists. After going live in 2022, the company grew revenue from €2 million that year to €12 million in 2023 and €25 million in 2024, and it projects surpassing €40 million in 2025. To date, Serenis has facilitated 1.5 million therapy sessions for consumers and for 250 enterprise customers via its Serenis Business offering, which counts Nestlé, Banca Sella, Satispay and Leroy Merlin among its clients. The company is extending its product suite with Serenis Nutrizione for eating disorders, opening physical Serenis Studio clinics in Milan and Rome, and rolling out Scribe AI, a GDPR-compliant tool that generates instant session summaries. Serenis employs 65 people and plans to add 30 more in the next year. Its mission is to make high-quality mental and physical wellbeing services more accessible by combining clinical rigor with proprietary technology.

Participated · Seed · Nov 2023

Qomodo is an all-in-one payment methods aggregator that brings buy-now-pay-later (BNPL) and POS solutions to physical merchants. Its core product lets consumers pay in flexible, interest-free installments in-store while the software aims to simplify merchant transactions and reduce payment fees and credit risk. The company says it serves about 2,500 physical merchants, mostly in Italy, and has partnerships with retailers including Decathlon, Calzedonia, Moschino, Samsonite, Nike and Pandora. Qomodo plans to expand beyond BNPL and POS by launching additional banking products such as cards and bank accounts. Financially, the startup has raised both equity and credit facilities, bringing total capital to date to €48 million (around $49.6M). Qomodo provides a Buy Now Pay Later suite and payments platform for physical retailers, combining an interest-free installment "Pay over time" product, a smartPOS "Pay now" terminal, and an online checkout plus Tap-to-phone "Pay now remotely" option. Its BNPL flow approves customers in approximately 30 seconds without payslips or paper documents, while the smartPOS accepts major card networks and the SoftPOS turns Android phones into card readers. The company says it served over 500 merchants during stealth and has agreements in progress to onboard thousands of physical retailers via API integrations. Co-founded in 2023 by Gianluca Cocco and Gaetano De Maio and based in Milan, Qomodo aims to expand operations and grow merchant reach. Financially, the company completed a €34.5M pre-seed funding round to support those expansion plans.

Participated · Equity · Apr 2022

Insoore, launched by Rome-headquartered Whoosnap, offers an alternative claims management model that digitises and accelerates document collection and claims processes. The platform provides insurance and fleet management companies access to a community of users who produce certified video and photographic documentation. The company says this approach saves time and costs for customers. It has raised €5.5 million to support product and commercial development. Proceeds will be used to develop AI projects in damage detection, recruit new talent and expand globally. Company leadership and investors expect the funding to drive strong revenue growth as the business scales.

Led · Seed · Feb 2022

Founded in 2017 and based in Rome, GenomeUp develops an AI-powered medical SaaS platform for genomic analysis and clinical decision support focused on rare genetic diseases. Its flagship product, JuliaOmix, enables physicians and genetic biologists to collaborate by combining patients' symptoms, treatments, phenotypes and omics data (whole genome, exome, microbiome). The platform produces AI-based clinical interpretation and reports of genomic variants to aid diagnosis and treatment planning. GenomeUp says its longer-term goal is to build a reference platform to accelerate diagnosis times, improve patient care, and deepen understanding of genetic diseases. The company has developed bioinformatics tools and protocols to make health data traceable, accessible, interoperable and reusable for researchers and clinicians. Its recent fundraising will be used to grow the team and continue platform development. GenomeUp is a Rome-based university spin-off that develops a genomic tool leveraging artificial intelligence to help doctors choose the best treatments for patients. The product analyzes a patient’s genome to generate detailed clinical reports on genes affecting pathology, the severity of new mutations, and personalized treatments by mining PubMed. The company plans to use recent funding to continue development efforts. GenomeUp recently completed the LUISS EnLabs accelerator run by LVenture Group. It has partnered with Ospedale Pediatrico Bambino Gesù and Policlinico Tor Vergata in Rome. Leadership includes CEO Simone Gardini, CTO Andrea Spinelli, and COO Andrea Cocco.

Led · Seed · Nov 2021

Macai operates an online grocery delivery platform focused on q‑commerce, offering about 7,500 products and rapid fulfillment via dark stores (intelligent warehouses) located in city centers. Deliveries are performed using electric bicycles and scooters. The company is led by CEO and co-founder Giovanni Cavallo and currently serves Milan and Turin, with additional openings planned. Macai raised funding to accelerate expansion of operations and business reach across Italy’s largest cities and later into the rest of Europe. The product mix and logistics are positioned to support quick, urban grocery deliveries and scalable city rollouts.